These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36598116)

  • 1. Proteoglycans in breast cancer, identification and characterization by LC-MS/MS assisted proteomics approach: A review.
    Kizhakkeppurath Kumaran A; Sahu A; Singh A; Aynikkattil Ravindran N; Sekhar Chatterjee N; Mathew S; Verma S
    Proteomics Clin Appl; 2023 Jul; 17(4):e2200046. PubMed ID: 36598116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic Analysis of Urine to Identify Breast Cancer Biomarker Candidates Using a Label-Free LC-MS/MS Approach.
    Beretov J; Wasinger VC; Millar EK; Schwartz P; Graham PH; Li Y
    PLoS One; 2015; 10(11):e0141876. PubMed ID: 26544852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of Glycosaminoglycans in Biological Specimens.
    Khan SA; Nidhi FNU; Amendum PC; Tomatsu S
    Methods Mol Biol; 2023; 2619():3-24. PubMed ID: 36662458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of pathway biomarkers from coupled proteomics and systems biology methods.
    Zhang F; Chen JY
    BMC Genomics; 2010 Nov; 11 Suppl 2(Suppl 2):S12. PubMed ID: 21047379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of MALDI Imaging Proteolytic Peptides Using LC-MS/MS-Based Biomarker Discovery Data: A Proof of Concept.
    Longuespée R; Ly A; Casadonte R; Schwamborn K; Kazdal D; Zgorzelski C; Bollwein C; Kriegsmann K; Weichert W; Kriegsmann J; Schirmacher P; Fresnais M; Oliveira C; Kriegsmann M
    Proteomics Clin Appl; 2019 Jan; 13(1):e1800158. PubMed ID: 30525291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative proteomic analysis of human plasma using tandem mass tags to identify novel biomarkers for herpes zoster.
    Wang T; Shen H; Deng H; Pan H; He Q; Ni H; Tao J; Liu S; Xu L; Yao M
    J Proteomics; 2020 Aug; 225():103879. PubMed ID: 32585426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel alternative splicing biomarkers for breast cancer with LC/MS/MS and RNA-Seq.
    Zhang F; Deng CK; Wang M; Deng B; Barber R; Huang G
    BMC Bioinformatics; 2020 Dec; 21(Suppl 9):541. PubMed ID: 33272210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LC-MS/MS-based targeted proteomics quantitatively detects the interaction between p53 and MDM2 in breast cancer.
    Zhang W; Zhong T; Chen Y
    J Proteomics; 2017 Jan; 152():172-180. PubMed ID: 27826076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous quantification of Cyt c interactions with HSP27 and Bcl-xL using molecularly imprinted polymers (MIPs) coupled with liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based targeted proteomics.
    Zhang W; Zhang T; Chen Y
    J Proteomics; 2019 Feb; 192():188-195. PubMed ID: 30237093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serial in-solution digestion protocol for mass spectrometry-based glycomics and proteomics analysis.
    Sethi MK; Downs M; Zaia J
    Mol Omics; 2020 Aug; 16(4):364-376. PubMed ID: 32309832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A large, consistent plasma proteomics data set from prospectively collected breast cancer patient and healthy volunteer samples.
    Riley CP; Zhang X; Nakshatri H; Schneider B; Regnier FE; Adamec J; Buck C
    J Transl Med; 2011 May; 9():80. PubMed ID: 21619653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic investigation on bio-corona of Au, Ag and Fe nanoparticles for the discovery of triple negative breast cancer serum protein biomarkers.
    Del Pilar Chantada-Vázquez M; López AC; Vence MG; Vázquez-Estévez S; Acea-Nebril B; Calatayud DG; Jardiel T; Bravo SB; Núñez C
    J Proteomics; 2020 Feb; 212():103581. PubMed ID: 31731051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uncovering molecular targets for regenerative therapy in degenerative disc disease: do small leucine-rich proteoglycans hold the key?
    Rajasekaran S; Soundararajan DCR; Tangavel C; Nayagam SM; K S SV; R S; Matchado MS; Muthurajan R; Shetty AP; Kanna RM; K D
    Spine J; 2021 Jan; 21(1):5-19. PubMed ID: 32344061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
    Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
    Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development and application of FD-LC-MS/MS proteomics analysis revealing protein expression and biochemical events in tissues and cells].
    Ichibangase T; Imai K
    Yakugaku Zasshi; 2015; 135(2):197-203. PubMed ID: 25747213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Site-specific glycosylation of proteoglycans: A revisited frontier in proteoglycan research.
    Noborn F; Nilsson J; Larson G
    Matrix Biol; 2022 Aug; 111():289-306. PubMed ID: 35840015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.
    Bouchal P; Roumeliotis T; Hrstka R; Nenutil R; Vojtesek B; Garbis SD
    J Proteome Res; 2009 Jan; 8(1):362-73. PubMed ID: 19053527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shotgun proteomics coupled to nanoparticle-based biomarker enrichment reveals a novel panel of extracellular matrix proteins as candidate serum protein biomarkers for early-stage breast cancer detection.
    Fredolini C; Pathak KV; Paris L; Chapple KM; Tsantilas KA; Rosenow M; Tegeler TJ; Garcia-Mansfield K; Tamburro D; Zhou W; Russo P; Massarut S; Facchiano F; Belluco C; De Maria R; Garaci E; Liotta L; Petricoin EF; Pirrotte P
    Breast Cancer Res; 2020 Dec; 22(1):135. PubMed ID: 33267867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An investigation of heat shock protein 27 and P-glycoprotein mediated multi-drug resistance in breast cancer using liquid chromatography-tandem mass spectrometry-based targeted proteomics.
    Xu F; Yang T; Fang D; Xu Q; Chen Y
    J Proteomics; 2014 Aug; 108():188-97. PubMed ID: 24882106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deep Sequencing of Complex Proteoglycans: A Novel Strategy for High Coverage and Site-specific Identification of Glycosaminoglycan-linked Peptides.
    Klein JA; Meng L; Zaia J
    Mol Cell Proteomics; 2018 Aug; 17(8):1578-1590. PubMed ID: 29773674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.